CORC

在结果中检索

CORC

浏览/检索结果: 共25条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients 期刊论文
CANCER MEDICINE, 2022
作者:  Hao, Yue;  Lin, Gen;  Xiang, Jing;  Wang, Wenxian;  Xu, Chunwei
收藏  |  浏览/下载：13/0  |  提交时间：2022/12/23
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor 期刊论文
THORACIC CANCER, 2022
作者:  Wang, Wenxian;  Wang, Qian;  Xu, Chunwei;  Li, Ziming;  Song, Zhengbo
收藏  |  浏览/下载：24/0  |  提交时间：2022/12/23
Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial 期刊论文
BRITISH JOURNAL OF CANCER, 2022
作者:  Qin, Shukui;  Li, Jin;  Zhong, Haijun;  Jin, Chuan;  Chen, Lili
收藏  |  浏览/下载：18/0  |  提交时间：2022/12/22
Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study 期刊论文
EUROPEAN JOURNAL OF CANCER, 2022, 卷号: 174
作者:  Wang, Wenxian;  Lin, Gen;  Guan, Yelan;  Zhang, Yuxin;  Xu, Chunwei
收藏  |  浏览/下载：15/0  |  提交时间：2022/12/23
Image classification of immune checkpoint inhibitor-related pneumonia in lung cancer patients 期刊论文
CLINICAL IMAGING, 2022, 卷号: 86
作者:  Sun, Xiaojun;  Song, Zhengbo;  Jiang, Hongyang;  Ma, Yanqing;  Chen, Ming
收藏  |  浏览/下载：8/0  |  提交时间：2022/12/23
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial 期刊论文
LANCET ONCOLOGY, 2022, 卷号: 23
作者:  Zhou, Qing;  Chen, Ming;  Jiang, Ou;  Pan, Yi;  Hu, Desheng
收藏  |  浏览/下载：98/0  |  提交时间：2022/03/21
Application of Noninvasive Imaging to Combined Immune Checkpoint Inhibitors for Breast Cancer: Facts and Future 期刊论文
MOLECULAR IMAGING AND BIOLOGY, 2022, 页码: 16
作者:  Cheng, Zhongquan;  Du, Yang;  Yu, Leyi;  Yuan, Zhu;  Tian, Jie
收藏  |  浏览/下载：42/0  |  提交时间：2022/03/17
Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China 期刊论文
THORACIC CANCER, 2021
作者:  Shi, Yuequan;  Fang, Jian;  Zhou, Chengzhi;  Liu, Anwen;  Wang, Yan
收藏  |  浏览/下载：61/0  |  提交时间：2022/01/25
The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study 期刊论文
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021
作者:  Wang, Wenxian;  Gu, Xiaodong;  Wang, Liping;  Pu, Xingxiang;  Feng, Huijing
收藏  |  浏览/下载：25/0  |  提交时间：2022/01/10
Safety and efficacy of combination therapy using programmed cell death protein-1/programmed cell death ligand-1 inhibitors and radiotherapy in patients with non-small-cell lung cancer: A systematic review and meta-analysis 期刊论文
CANCER MEDICINE, 2021, 页码: 19
作者:  Geng, Yichao;  Zhang, Qiuning;  Feng, Shuangwu;  Li, Chengcheng;  Wang, Lina
收藏  |  浏览/下载：26/0  |  提交时间：2021/12/10

©版权所有 ©2017 CSpace - Powered by CSpace